LEDGF and HDGF2 relieve the nucleosome-induced barrier to transcription in differentiated cells

Gary LeRoy(Howard Hughes Medical Institute), Ozgur Oksuz(Howard Hughes Medical Institute), Nicolas Descostes(Howard Hughes Medical Institute), Yuki Aoi(Northwestern University), Rais A. Ganai(Howard Hughes Medical Institute), Havva Ortabozkoyun(Howard Hughes Medical Institute), Jia-Ray Yu(Howard Hughes Medical Institute), Chul‐Hwan Lee(Howard Hughes Medical Institute), James M. Stafford(Howard Hughes Medical Institute), Ali Shilatifard(Northwestern University), Danny Reinberg(Howard Hughes Medical Institute)
Science Advances
October 2, 2019
Cited by 92Open Access
Full Text

Abstract

FACT (facilitates chromatin transcription) is a protein complex that allows RNA polymerase II (RNAPII) to overcome the nucleosome-induced barrier to transcription. While abundant in undifferentiated cells and many cancers, FACT is not abundant or is absent in most tissues. Therefore, we screened for additional proteins that might replace FACT upon differentiation. We identified two proteins, lens epithelium-derived growth factor (LEDGF) and hepatoma-derived growth factor 2 (HDGF2), each containing two high mobility group A (HMGA)-like AT-hooks and a methyl-lysine reading Pro-Trp-Trp-Pro (PWWP) domain that binds to H3K36me2 and H3K36me3.LEDGF and HDGF2 colocalize with H3K36me2/3 at genomic regions containing active genes. In myoblasts, LEDGF and HDGF2 are enriched on most active genes. Upon differentiation to myotubes, LEDGF levels decrease, while HDGF2 levels are maintained. Moreover, HDGF2 is required for their proper expression. HDGF2 knockout myoblasts exhibit an accumulation of paused RNAPII within the transcribed region of many HDGF2 target genes, indicating a defect in early elongation.


Related Papers

No related papers found

Powered by citation graph analysis